Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
Mauro Gitto, Interventional Cardiologist at Humanitas Research Hospital, shared on LinkedIn:
”Our latest article comparing two contemporary paclitaxel-coated balloons (urea-coated Prevail vs iopromide-coated Sequent Please) for the treatment of both de novo and ISR lesions.
As evidence in support of DCB-based PCI grows, more and more device-comparing studies are needed!
Full text here.”
Read the full article here.
Article: Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
Authors: Mauro Gitto, Francesco Tartaglia, Pier Pasquale Leone, Gianmaria Calamita, Alessandro Gabrielli, Leon Gramss, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Bernhard Reimers, Giulio Giuseppe Stefanini, Antonio Mangieri, Azeem Latib, Antonio Colombo
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 21, 2026, 11:34Martha Gulati: How Does Lp(a) Drive Atherosclerosis?
-
Mar 21, 2026, 11:28Raphael Escaig: The Roles of Platelets in Inflammation Beyond Hemostasis
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH